In the first book of its kind, Leo Huberts provides a critical synthesis of cutting-edge research on public sector integrity exploring issues such as the definition and importance of public sector integrity, the various methodological approaches to the field as well as considering the causes of for the violation of values associated with integrity.

This report provides concrete recommendations for strengthening the legislative and institutional framework for elected and appointed officials in Malta. It reviews the institutional and procedural set-up of the Commissioner for Standards in Public Life and analyses the omissions, inconsistencies and overlaps in the Standards in Public Life Act.

This report looks at how to curb corruption and build a more competitive economy in the Republic of Kazakhstan by assessing four crucial factors: governance, prevention, detection, and prosecution and recovery.

This review analyses Thailand’s integrity system. It takes stock of the country's recent efforts to tackle corruption, such as the creation of anti-corruption commissions and legislation.

Up to date reviews, along with fresh future perspectives. Focusing on Europe and the US, it addresses the key dimensions of public service values, the integrity and rationality of governance, ethics management, and the ethics of governance politics.

The OECD Recommendation on Public Integrity puts risk management at the heart of any strategy or approach to ensure and promote public integrity. This report reviews the current integrity risk assessment methodology in the Brazilian federal executive branch through the lens of behavioural insights and the use of data.

The OECD Integrity Review of Thailand 2021 assesses three key elements of Thailand’s integrity system: disciplinary mechanisms and sanctions, risk management, and integrity in policy and decision making in the public sector.

Costa Rica is seeking to consolidate democratic gains to safeguard trust in government and build economic resilience. This Integrity Review looks at how Costa Rica can translate its recent National Strategy for Integrity and Prevention of Corruption into a concrete and coherent integrity policy.

Data integrity is the hottest topic in the pharmaceutical industry. Global regulatory agencies have issued guidance, after guidance after guidance in the past few years, most of which does not offer practical advice on how to implement policies, procedures and processes to ensure integrity. These guidances state what but not how. Additionally, key stages of analysis that impact data integrity are omitted entirely. The aim of this book is to provide practical and detailed help on how to implement data integrity and data governance for regulated analytical laboratories working in or for the pharmaceutical industry. It provides clarification of the regulatory issues and trends, and gives practical methods for meeting regulatory requirements and guidance. Using a data integrity model as a basis, the principles of data integrity and data governance are expanded into practical steps for regulated laboratories to implement. The author uses case study examples to illustrate his points and provides instructions for applying the principles of data integrity and data governance to individual laboratory needs. This book is a useful reference for analytical chemists and scientists, management and senior management working in regulated laboratories requiring either an understanding about data integrity or help in implementing practical solutions. Consultants will also benefit from the practical guidance provided.

Data integrity is a critical aspect to the design, implementation, and usage of any system which stores, processes, or retrieves data. The overall intent of any data integrity technique is the same: ensure data is recorded exactly as intended and, upon later retrieval, ensure the data is the same as it was when originally recorded. Any alternation to the data is then traced to the person who made the modification. The integrity of data in a patient’s electronic health record is critical to ensuring the safety of the patient. This book is relevant to production systems and quality control systems associated with the manufacture of pharmaceuticals and medical device products and updates the practical information to enable better understanding of the controls applicable to e-records. The book highlights the e-records suitability implementation and associated risk-assessed controls, and e-records handling. The book also provides updated regulatory standards from global regulatory organizations such as MHRA, Medicines and Healthcare Products Regulatory Agency (UK); FDA, Food and Drug Administration (US); National Medical Products Association (China); TGA, Therapeutic Goods Administration (Australia); SIMGP, Russia State Institute of Medicines and Good Practices; and the World Health Organization, to name a few.